OncoZenge AB (publ)

kr 3.15As of Sun 8 Nov 2026, 12:00 UTC
STO:ONCOZHealthcare
Country Sweden
PE (Fwd) •••
TSR 6Y CAGR (17.37%)
Div yield —
ROE (231.25%)
Biotechnology
Beta (5Y) 1.40
PE TTM —
TSR TTM (27.56%)
Mkt cap kr 87.08M
ROIC (106.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 3.27
3.52%
(32.94%)
Hold 4|4|4|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.03
0.04
0.04
0.04
10.75%
12.70%
27.10%
31.58%
Revenuekr M
6.202
6.336
6.218
6.234
10.27%
7.71%
3.64%
5.38%
Peers (US$8.804M)
Cap (US$)
PE
8.797M
—
Capital
TTM
5Y
10Y
Leveragex
1.023
(0.467)
(0.496)
EBIT/Intx
2.882
1.129
1.259
Own earn%
(74.93)
(81.07)
(75.73)
Sh yield%
24.42
48.43
47.46
Owners
Insiders/Inst%
12.38
76.96
Short interest%
1.43
SBC / revenue%
2.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
17–25
$1 testx
—
Incr. ROIC%
1